CAS: 16034-77-8; 3-(N-(3-Amino-2,4,6-Triiodophenyl)Acetamido)-2-Methylpropanoic Acid

该化合物是一种三碘芳香化合物,有可能用作中间抗反转剂合成,其结构具有高碘含量,这对医疗成像中的X射线衰减特性至关重要,乙酰胺和碳酸箱酸组的存在提高了溶性和衍生潜力,有利于进一步的化学改造.该化合物的稳定性和界定的立体化学使其适合对诊断剂进行有控制的合成.其特征精细的再活性使得能够精确功能化,支持有针对性的对比介质的开发,并改进了药用基因特征.这一介质因其在研究和工业应用中的纯度和一致性而受到重视.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-2022233673-A1
    优先权日:2019-06-04
    标 题:METHODS OF PRODUCING SHIGA TOXIN B-SUBUNIT (STxB) MONOMERS AND OLIGOMERS, AND USES THEREOF
    发明人:BILLET ANNE; SCHMIDT FRÉDÉRIC; JOHANNES LUDGER; SERVENT DENIS; MOURIER GILLES; TARTOUR ÉRIC; KAY MICHAEL; FULCHER JAMES M
    权利人:INST CURIE; CENTRE NAT RECH SCIENT; INST NAT SANTE RECH MED; COMMISSARIAT A LENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES CEA; APHP ASSIST PUBLIQUE HOPITAUX DE PARIS; UNIV PARIS; UNIV OF UTAH RESEARCH FOUDATION; UNIV UTAH RES FOUND
    摘要:A method of producing a monomer of a Shiga toxin B-subunit (STxB) protein or of a variant thereof by peptide chemical synthesis, as well as to a method of producing a pentamer of the STxB protein or of the variant thereof. The methods are particularly advantageous as they overcome major issues typically observed in peptide chemical synthesis, including solubility and purity issues.

    专利号:US-11466046-B2
    优先权日:2014-10-08
    标题 :14-membered ketolides and methods of their preparation and use
    发明人:MYERS ANDREW G; SEIPLE IAN BASS; ZHANG ZIYANG
    权利人:HARVARD COLLEGE
    摘要:Provided herein are methods of preparing new 14-membered ketolides via coupling of an eastern and western half moiety, followed by macrocyclization, and optional functionalization. Intermediates in the synthesis of these ketolides including the eastern and western halves are also provided. Pharmaceutical compositions and methods of treating infectious diseases and inflammatory conditions using these ketolides are also provided.

    专利号:US-2016138027-A1
    优先权日:2013-03-14
    标 题:Treatment of diseases and conditions associated with dysregulation of mammalian target of rapamycin complex 1 (mtorc1)
    发明人:GAN LIN; MEYER TOBIAS
    权利人:UNIV LELAND STANFORD JUNIOR
    摘要:Compositions and methods for treating diseases and conditions associated with dysregulation of mammalian target of rapamycin complex 1 (mTORC1) are disclosed. The invention is based in part on the discovery that protein mediator of amino acid signaling to mTOR (MORTOR) is involved in amino acid-induced translocation of mTORC1 to lysosomes where MORTOR forms a signaling complex with mTORC1, Ragulator, and Rag GTPases, which controls protein synthesis. In particular, the invention relates to the use of antagonists of MORTOR for treating diseases and conditions associated with dysregulation of mTORC1. Downregulation of expression of MORTOR by RNA interference has been shown to reduce cell proliferation of cancerous cells and may be useful for treating cancer.

    专利号:US-2022233727-A1
    优先权日:2019-06-13
    标题:Surface enhanced raman scattering nanoparticles and their use in detecting and imaging oxidative stress
    发明人:THAKOR AVNESH S; RAZAVI MEHDI
    权利人:UNIV LELAND STANFORD JUNIOR
    摘要:Surface enhanced Raman scattering (SERS) nanoparticles and methods of using them for detecting reactive oxygen species are disclosed. In particular, methods of using SERS nanoparticles to detect and quantify reactive oxygen species Synthesis and monitor oxidative stress and disease-relevant changes in levels of reactive oxygen species are provided.

    专利号:US-2014315720-A1
    优先权日:2012-10-24
    标 题 :Polysaccharide ester microspheres and methods and articles relating thereto
    发明人:FALLON DENIS G; GARRETT THOMAS S; KIZER LAWTON E; ZAZZARA KAREN L; COMBS MICHAEL T; JOHNSON RICHARD K; DEHART GARY
    权利人:CELANESE ACETATE LLC
    摘要:A method for producing a polysaccharide ester microsphere may include forming a polysaccharide ester product from a polysaccharide synthesis, wherein the polysaccharide ester product comprises a polysaccharide ester and a solvent; diluting the polysaccharide ester product, thereby yielding a polysaccharide ester dope; and forming a plurality of polysaccharide ester microspheres from the polysaccharide ester dope. Suitable polysaccharides may include, but are not limited to, starch, cellulose, hemicellulose, algenates, chitosan, and any combination thereof. Esters thereof may be organic esters (e.g., acetate and the like), inorganic esters (e.g., sulfonates and the like), or combinations thereof. Further, the solids conent of the polysaccharide ester dope, in some instances, may be greater than about 16 wt %.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Staubus AE, Berk RN, Loeb PM, Barnhart JL. Saturation kinetics of iocetamic acid: Evaluation of indirect pharmacokinetic techniques and comparison with iopanoic acid. Invest Radiol. 1978 Jan-Feb;13(1):85-92. doi: 10.1097/00004424-197801000-00017. 14(1):79-87. doi: 10.1097/00004424-197901000-00013. 2004–2013. 30(1):45-8. doi: 10.1016/s0009-9260(79)80041-0. 29(5):535-40. doi: 10.1016/s0009-9260(78)80046-4. 14(2):242-8. doi: 10.1016/0041-008x(69)90104-5. 16(1):103. doi: 10.1002/ajh.2830160115. 14(2):232-41. doi: 10.1016/0041-008x(69)90103-3. 37(6):338-52. 54(637):79-80. doi: 10.1259/0007-1285-54-637-79.

    合成参考文献


    摘要:Toxicology and Applied Pharmacology., 14(232), 1969 []
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知